ResearcherNational Yang Ming Chiao Tung UniversityNo recent work listed

Chih-Hong Wang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5039401710. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 3)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 3

Papers, trials and grants by year

2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 3

Elevated Circulating Levels of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline ( AcSDKP) Involved in Pancreatic Cancer Development Last author DOI 10.21203/rs.3.rs-23986/v1 ↗
Prorenin receptor acts as a potential molecular target for pancreatic ductal adenocarcinoma diagnosis. Last author DOI 10.18632/oncotarget.10583 ↗
Increased serum levels of betatrophin in pancreatic cancer-associated diabetes. Last author DOI 10.18632/oncotarget.9815 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hendra Susanto · 2 shared papers, 2016–2020 · strength 0.23
- Paper Elevated Circulating Levels of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline ( AcSDKP) Involved in Pancreatic Cancer Development DOI 10.21203/rs.3.rs-23986/v1 ↗
- Paper Increased serum levels of betatrophin in pancreatic cancer-associated diabetes. DOI 10.18632/oncotarget.9815 ↗
Arundhathi Arivajiagane · 1 shared paper, 2016 · strength 0.05
- Paper Prorenin receptor acts as a potential molecular target for pancreatic ductal adenocarcinoma diagnosis. DOI 10.18632/oncotarget.10583 ↗
Shin‐E Wang · 1 shared paper, 2016 · strength 0.05
- Paper Prorenin receptor acts as a potential molecular target for pancreatic ductal adenocarcinoma diagnosis. DOI 10.18632/oncotarget.10583 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.